To improve cell uptake and plasma stability, Ghaffari et al. (Ghaffari et al., 2021) optimized cationic niosomes to target the Bcl-2 gene by co-encapsulating miR-15a and miR-16-1 for the treatment of prostate cancer. Here, BCL2 is linked to prostate cancer.